Finding new chemical probes to help in drug discovery
Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches
This study is all about finding better tools to help create new medicines by using smart computer techniques to identify and test molecules that can target proteins linked to diseases, which could lead to more effective treatments for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10837056 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods to discover high-quality chemical probes that can specifically target proteins involved in diseases. By integrating advanced computational techniques and crystallographic data, the project aims to accelerate the identification and optimization of these probes. Patients may benefit from this research as it seeks to enhance drug discovery processes, potentially leading to more effective treatments. The approach involves using artificial intelligence to predict how new molecules will interact with target proteins, followed by experimental validation.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that currently lack effective treatments due to the limited availability of specific chemical probes.
Not a fit: Patients with well-established treatments and no need for new drug development may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs that are more effective and targeted for various diseases.
How similar studies have performed: Other research initiatives have shown promise in using computational methods for drug discovery, but this specific integrative approach is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Tropsha, Alexander — Univ of North Carolina Chapel Hill
- Study coordinator: Tropsha, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.